View More View Less
  • 1 Fachbereich Tropenmedizin am Bernhard-Nocht-Institut, Bundeswehrkrankenhaus Hamburg, Hamburg, Germany
  • 2 Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsklinikum Rostock, Rostock, Germany
  • 3 Praxis Dr. Jungblut, Frankfurt am Main, Germany
  • 4 Abteilung für Pneumologie, Deutsche Klinik für Diagnostik (DKD), Wiesbaden, Germany
  • 5 Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen, Göttingen, Germany
  • 6 Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen, Kreuzbergring 57, D-37075, Göttingen, Germany
Restricted access

Abstract

This review explores the extensive influence of viral infections leading to chronic deterioration of lung function in patients with cystic fibrosis (CF). The mechanisms how viral agents affect the pathogenesis as well as the inflammatory and immune response of CF are discussed. Viral infections of the upper and lower respiratory tract due to viruses in CF patients and methods for diagnosis of respiratory viruses are described in detail. The importance of respiratory and non-respiratory viral agents for the pathogenesis, especially for the exacerbation of bacterial lower respiratory tract infections and course of CF, is stressed, especially emphasizing respiratory syncytial virus, influenza virus, rhinovirus, and human herpes viruses. Possible harmful effects of further viruses like adenovirus, bocavirus, coronavirus, metapneumovirus, parainfluenzavirus on the lung function of CF patients are discussed. The potential use of adenovirus-based vectors for somatic gene therapy is mentioned.

  • 1. S. Rajan L. Saiman 2002 Pulmonary infections in patients with cystic fibrosis Semin Respir Infect 17 1 4756.

  • 2. D. Wat 2003 Impact of respiratory viral infections on cystic fibrosis Postgrad Med J 79 930 201203.

  • 3. S.H. Abman 1991 Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening J Pediatr 119 2 211217.

    • Search Google Scholar
    • Export Citation
  • 4. M.M. Tunney 2008 Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis Am J Respir Crit Care Med 177 9951001.

    • Search Google Scholar
    • Export Citation
  • 5. I.M. Jørgensen 2003 Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients Pediatr Pulmonol 36 5 439446.

    • Search Google Scholar
    • Export Citation
  • 6. J.E. Moore 2002 Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identification Br J Biomed 59 3 164166.

    • Search Google Scholar
    • Export Citation
  • 7. C. Pitulle 1999 Novel bacterium isolated from a lung transplant patient with cystic fibrosis J Clin Microbiol 37 12 38513855.

  • 8. R. Chiron 2005 Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis J Clin Microbiol 43 8 39383943.

    • Search Google Scholar
    • Export Citation
  • 9. N. Wellinghausen 2005 Inquilinus limosus in patients with cystic fibrosis, Germany Emerg Infect Dis 11 3 457459.

  • 10. N.L. Hordvik 1989 Effects of acute viral respiratory tract infections in patients with cystic fibrosis Pediatr Pulmonol 7 4 217222.

    • Search Google Scholar
    • Export Citation
  • 11. J. Stroobant 1986 Viral infection in cystic fibrosis J R Soc Med 79Suppl12 1922.

  • 12. D.J. Shale 1992 Viral infections: a role in the lung disease of cystic fibrosis? Thorax 47 2 69.

  • 13. W. Xu 2006 Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection J Interferon Cytokine Res 26 9 609627.

    • Search Google Scholar
    • Export Citation
  • 14. E.E. Wang 1984 Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis N Engl J Med 311 26 16531658.

    • Search Google Scholar
    • Export Citation
  • 15. D. Wat 2008 The role of respiratory viruses in cystic fibrosis J Cyst Fibros 7 4 320328.

  • 16. D. Wat I. Doull 2003 Respiratory virus infections in cystic fibrosis Paediatr Respir Rev 4 3 172177.

  • 17. B.E. van Ewijk 2005 Viral respiratory infections in cystic fibrosis J Cyst Fibros 4 Suppl2 3136.

  • 18. B.W. Ramsey 1989 The effect of respiratory viral infections on patients with cystic fibrosis Am J Dis Child 143 6 662668.

  • 19. C.G. Prober 1991 The impact of respiratory viral infections in patients with cystic fibrosis Clin Rev Allergy 9 1–2 87102.

  • 20. I.J. Clifton 2008 Ten years of viral and non-bacterial serology in adults with cystic fibrosis Epidemiol Infect 136 1 128134.

  • 21. E.L. Ong 1989 Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms Thorax 44 9 739742.

    • Search Google Scholar
    • Export Citation
  • 22. D. Armstrong 1998 Severe viral respiratory infections in infants with cystic fibrosis Pediatr Pulmonol 26 6 371379.

  • 23. F. Freymouth 2003 Presence of the new human metapneumovirus in French children with bronchiolitis Pediatr Infect Dis J 22 1 9294.

    • Search Google Scholar
    • Export Citation
  • 24. H.V. Olesen 2006 Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic Pediatr Pulmonol 41 12 11971204.

    • Search Google Scholar
    • Export Citation
  • 25. D.S. Armstrong 1995 Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis BMJ 310 6994 15711572.

    • Search Google Scholar
    • Export Citation
  • 26. G. Punch 2005 Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis Eur J Clin Microbiol Infect Dis 24 1 5457.

    • Search Google Scholar
    • Export Citation
  • 27. J. Kuypers 2006 Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children J Clin Microbiol 44 7 23822388.

    • Search Google Scholar
    • Export Citation
  • 28. F. Watzinger 2004 Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients J Clin Microbiol 42 11 51895198.

    • Search Google Scholar
    • Export Citation
  • 29. X. Lu 2006 Real-time PCR assays for detection of bocavirus in human specimens J Clin Microbiol 44 9 32313235.

  • 30. J. Kuypers 2007 Clinical disease in children associated with newly described coronavirus subtypes Pediatrics 119 1 e7076.

  • 31. M. Schulze 2010 Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR PLoS One 5 4 e9966.

    • Search Google Scholar
    • Export Citation
  • 32. E. Spackman 2002 Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes J Clin Microbiol 40 9 32563260.

    • Search Google Scholar
    • Export Citation
  • 33. C.W. Lee D.L. Suarez 2004 Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus J Virol Methods 119 2 151158.

    • Search Google Scholar
    • Export Citation
  • 34. J. Kuypers 2005 Detection and quantification of human metapneumovirus in pediatric specimens by real-time RTPCR J Clin Virol 33 4 299305.

    • Search Google Scholar
    • Export Citation
  • 35. S.K. Lau 2005 Human parainfluenza virus 4 outbreak and the role of diagnostic tests J Clin Microbiol 43 9 45154521.

  • 36. A. Pitkäranta 1997 Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR J Clin Microbiol 35 7 17911793.

    • Search Google Scholar
    • Export Citation
  • 37. J. Nokso-Koivisto 2002 Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms J Med Virol 66 3 417420.

    • Search Google Scholar
    • Export Citation
  • 38. J. Kuypers 2004 Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children J Clin Virol 31 2 123129.

    • Search Google Scholar
    • Export Citation
  • 39. X. Lu 2008 Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses J Clin Microbiol 46 2 533539.

    • Search Google Scholar
    • Export Citation
  • 40. W.A. Nix 2006 Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens J Clin Microbiol 44 8 26982704.

    • Search Google Scholar
    • Export Citation
  • 41. K.J. Henrickson C.B. Hall 2007 Diagnostic assays for respiratory syncytial virus disease Pediatr Infect Dis J 26 11Suppl S3640.

  • 42. N. Principi S. Esposito 2009 Antigen-based assays for the identification of influenza virus and respiratory syncytial virus: why and how to use them in pediatric practice Clin Lab Med 29 4 649660.

    • Search Google Scholar
    • Export Citation
  • 43. T. Popow-Kraupp J.H. Aberle 2011 Diagnosis of respiratory syncytial virus infection Open Microbiol J 5 128134.

  • 44. M.L. Landry 2011 Diagnostic tests for influenza infection Curr Opin Pediatr 23 1 9197.

  • 45. J. Collinson 1996 Effects of upper respiratory tract infections in patients with cystic fibrosis Thorax 51 11 11151122.

  • 46. B.E. van Ewijk 2008 Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study Pediatrics 122 6 11711176.

    • Search Google Scholar
    • Export Citation
  • 47. Burns JL et al.: Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respi Viruses. doi: 10.1111/j.1750-2659.2011.00292.x. [Epub ahead of print] (2011).

    • Search Google Scholar
    • Export Citation
  • 48. G. Gerna 2009 Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients J Med Virol 81 8 14981507.

    • Search Google Scholar
    • Export Citation
  • 49. A.R. Smyth 1995 Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis Arch Dis Child 73 2 117120.

    • Search Google Scholar
    • Export Citation
  • 50. P.W. Hiatt 1999 Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis Pediatrics 103 3 619626.

    • Search Google Scholar
    • Export Citation
  • 51. S.H. Abman 1988 Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis J Pediatr 113 5 826830.

    • Search Google Scholar
    • Export Citation
  • 52. K. Giebels 2008 Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis Pediatr Pulmonol 43 2 169174.

    • Search Google Scholar
    • Export Citation
  • 53. K.A. Shadman E.R. Wald 2011 A review of palivizumab and emerging therapies for respiratory syncytial virus Expert Opin Biol Ther 11 11 14551467.

    • Search Google Scholar
    • Export Citation
  • 54. Robinson KA et al.: Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database Syst Rev 2, CD007743 (2012).

    • Search Google Scholar
    • Export Citation
  • 55. Paes B et al.: Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations. Eur J Pediatr. [Epub ahead of print] (2011).

    • Search Google Scholar
    • Export Citation
  • 56. S. Ghosh 2001 Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins Bone Marrow Transplant 28 3 271275.

    • Search Google Scholar
    • Export Citation
  • 57. K.M. Empey 2010 Pharmacologic advances in the treatment and prevention of respiratory syncytial virus Clin Infect Dis 50 9 12581267.

    • Search Google Scholar
    • Export Citation
  • 58. L.R. Krilov 2011 Respiratory syncytial virus disease: update on treatment and prevention Expert Rev Anti Infect Ther 9 1 2732.

  • 59. M.C. Dunn 2011 Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide Antivir Ther 16 3 309317.

    • Search Google Scholar
    • Export Citation
  • 60. P.A. Piedra 1996 Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis Pediatr Infect Dis J 15 1 2331.

    • Search Google Scholar
    • Export Citation
  • 61. P.A. Piedra 1998 Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis Pediatr Infect Dis J 17 3 217224.

    • Search Google Scholar
    • Export Citation
  • 62. P.A. Piedra 2003 Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis Vaccine 21 19–20 24482460.

    • Search Google Scholar
    • Export Citation
  • 63. D.F. Garcia 2007 Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis Pediatr Pulmonol 42 1 6674.

    • Search Google Scholar
    • Export Citation
  • 64. B.G. van den Hoogen 2001 A newly discovered human pneumovirus isolated from young children with respiratory tract disease Nat Med 7 6 719724.

    • Search Google Scholar
    • Export Citation
  • 65. S.P. Conway 1992 Acute severe deterioration in cystic fibrosis associated with influenza A virus infection Thorax 47 2 112114.

  • 66. L. Viviani 2011 Impact of the A (H1N1) pandemic influenza (season 2009–2010) on patients with cystic fibrosis J Cyst Fibros 10 5 370376.

    • Search Google Scholar
    • Export Citation
  • 67. M.J. Ferson 1991 Impact of influenza on morbidity in children with cystic fibrosis J Paediatr Child Health 27 5 308311.

  • 68. C.G. Pribble 1990 Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections J Pediatr 117 2Pt1 200204.

    • Search Google Scholar
    • Export Citation
  • 69. D. Wat 2008 Is there a role for influenza vaccination in cystic fibrosis? J Cyst Fibros 7 1 8588.

  • 70. P. Adlard K. Bryett 1987 Influenza immunization in children with cystic fibrosis J Int Med Res 15 6 344351.

  • 71. W.C. Gruber 1994 Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study J Infect Dis 169 2 241247.

    • Search Google Scholar
    • Export Citation
  • 72. U.B. Schaad 2000 Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis Antimicrob Agents Chemother 44 5 11631167.

    • Search Google Scholar
    • Export Citation
  • 73. Tan A et al.: Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev (2), CD001753 (2000).

  • 74. P.F. Wright 1976 Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis J Infect Dis 134 2 144149.

    • Search Google Scholar
    • Export Citation
  • 75. V.A. Jagannath 2010 Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis Cochrane Database Syst Rev 17 3 CD008139.

    • Search Google Scholar
    • Export Citation
  • 76. V. Jullien 2011 Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis Antimicrob Agents Chemother 55 9 41834187.

    • Search Google Scholar
    • Export Citation
  • 77. T. Jartti 2012 Human bocavirus-the first 5 years Rev Med Virol 22 1 4664.

  • 78. Koseki N et al.: Detection of human bocavirus 1–4 from nasopharyngeal swab samples collected from patients with respiratory tract infections. J Clin Microbiol [Epub ahead of print] (2012).

    • Search Google Scholar
    • Export Citation
  • 79. N. Edner 2012 Life-threatening respiratory tract disease with human bocavirus-1 infection in a 4-year-old child J Clin Microbiol 50 2 531532.

    • Search Google Scholar
    • Export Citation
  • 80. G.B. Winnie R.G. Cowan 1992 Association of Epstein-Barr virus infection and pulmonary exacerbations in patients with cystic fibrosis Pediatr Infect Dis J 11 9 722726.

    • Search Google Scholar
    • Export Citation
  • 81. E.L. Ong 1991 Varicella-zoster infection in adults with cystic fibrosis: role of acyclovir Scand J Infect Dis 23 3 283285.

  • 82. A. Malfroot 2005 Immunisation in the current management of cystic fibrosis patients J Cyst Fibros 4 2 7787.

  • 83. E.H. Oppenheimer J.R. Esterly 1973 Letter: Congenital cytomegalovirus infection and bile duct obstruction in newborn infant with cystic fibrosis of pancreas Lancet 2 7836 10311032.

    • Search Google Scholar
    • Export Citation
  • 84. S.A. Kakabadze V.P. Tumanov 1993 Generalized herpes with mucoviscidosis, pneumocystosis and meconial disease-rare causes of death in newborn infants Sud Med Ekspert 36 2 812.

    • Search Google Scholar
    • Export Citation
  • 85. D.S. Armstrong 2005 Lower airway inflammation in infants with cystic fibrosis detected by newborn screening Pediatr Pulmonol 40 6 500510.

    • Search Google Scholar
    • Export Citation
  • 86. S. Zheng 2003 Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis Immunity 18 5 619630.

    • Search Google Scholar
    • Export Citation
  • 87. A.A. Stecenko 2001 Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells Inflammation 25 3 145155.

    • Search Google Scholar
    • Export Citation
  • 88. T.S. Blackwell 2001 Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder Am J Physiol Lung Cell Mol Physiol 281 1 L6970.

    • Search Google Scholar
    • Export Citation
  • 89. R.C. Strunk 1977 Serum complement depression during viral lower respiratory tract illness in cystic fibrosis Arch Dis Child 52 9 687690.

    • Search Google Scholar
    • Export Citation
  • 90. C.J. Dakin 2002 Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis Am J Respir Crit Care Med 165 7 904910.

    • Search Google Scholar
    • Export Citation
  • 91. M. Resti 1990 False diagnosis of non-A/non-B hepatitis hiding two cases of cystic fibrosis Eur J Pediatr 150 2 9799.

  • 92. J. Rosenecker 1996 Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer Infection 24 1 58.

    • Search Google Scholar
    • Export Citation
  • 93. N.T. Eissa 1994 Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a-adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis Hum Gene Ther 5 9 11051114.

    • Search Google Scholar
    • Export Citation
  • 94. J.A. Wagner 1999 Safety and biological efficacy of an adenoassociated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus Laryngoscope 109 2Pt1 266274.

    • Search Google Scholar
    • Export Citation
  • 95. P.A. Piedra 1998 Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors Pediatrics 101 6 10131019.

    • Search Google Scholar
    • Export Citation
  • 96. F. Gaden 2002 Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator-deficient human tracheal gland cells to adenovirus infection and admediated gene transfer Am J Respir Cell Mol Biol 27 5 628640.

    • Search Google Scholar
    • Export Citation
  • 97. Y. Yang 1994 Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 7 3 362369.

    • Search Google Scholar
    • Export Citation
  • 98. T.R. Flotte 2003 Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study Hum Gene Ther 14 11 10791088.

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2020 0 27 4
Jul 2020 7 6 1
Aug 2020 4 0 0
Sep 2020 1 0 0
Oct 2020 4 0 0
Nov 2020 7 0 0
Dec 2020 0 0 0